Congress 117 - HR 2379 - State Opioid Response Grant Authorization Act of 2021

Sponsor

Cosponsors

Topics

Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Health Health care coverage and access Health care quality Health programs administration and funding Health promotion and preventive care Prescription drugs State and local government operations

Full Text

View Full Bill Text

Votes

Summary

State Opioid Response Grant Authorization Act of 2021

This bill reauthorizes through FY2027 and otherwise changes the State Opioid Response Grant program. This program, which is managed by the Substance Abuse and Mental Health Services Administration, provides funding for states, territories, and Indian tribes and tribal organizations to address the opioid crisis.

Specific changes to the program include (1) expanding its scope to also address stimulant use and misuse, (2) establishing a funding methodology and minimum funding allocations, and (3) allowing the use of grant funds for recovery support services.

The bill also requires the Government Accountability Office to report on issues concerning the funding and other aspects of the program.

Actions

Oct 21, 2021

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Oct 20, 2021

Motion to reconsider laid on the table Agreed to without objection.
Oct 20, 2021

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 380 - 46 (Roll no. 320). (text: CR 10/19/2021 H5647-5648)
Oct 20, 2021

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 380 - 46 (Roll no. 320).(text: CR 10/19/2021 H5647-5648)
Oct 20, 2021

Considered as unfinished business. (consideration: CR H5699-5700)
Oct 19, 2021

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Oct 19, 2021

DEBATE - The House proceeded with forty minutes of debate on H.R. 2379.
Oct 19, 2021

Considered under suspension of the rules. (consideration: CR H5647-5650)
Oct 19, 2021

Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Oct 19, 2021

Placed on the Union Calendar, Calendar No. 109.
Oct 19, 2021

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-149.
Jul 21, 2021

Ordered to be Reported (Amended) by Voice Vote.
Jul 21, 2021

Committee Consideration and Mark-up Session Held.
Jul 15, 2021

Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Jul 15, 2021

Subcommittee Consideration and Mark-up Session Held.
Apr 13, 2021

Referred to the Subcommittee on Health.
Apr 8, 2021

Referred to the House Committee on Energy and Commerce.
Apr 8, 2021

Introduced in House

Amendments

Related Bills